VIR BIOTECHNOLOGY, INC. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 8,46 USD | +1,08% |
|
+4,06% | -15,90% |
| 26/04 | Cytokinetics benoemt Sung Lee tot CFO | MT |
| 18/04 | Vir Biotechnology, Inc. kondigt aan dat Sung Lee met ingang van 3 mei 2024 zal aftreden als uitvoerend vicepresident | CI |
Grafiek agenda Vir Biotechnology, Inc.
419c8c3c.58wPIrvgFYbHicd1FeK7j2n47JZYwae0UWzbp5SbcZc.pIF8aPiaZ8Gv660setSPx1HJhvsquMj6HAXuyuXwBdmmujlz1aEm3_689w~476d9cf8753de7bd7424f0f8e5514120
Komende gebeurtenissen op Vir Biotechnology, Inc.
Gebeurtenissen op naam
| 13-03-2024 12:30 | Barclays Global Healthcare Conference |
| 11-03-2024 | Leerink Partners Global Biopharma Conference |
| 04-03-2024 20:50 | TD Cowen Health Care Conference |
| 22-02-2024 22:30 | Q4 2023 Presentatie van de resultaten |
| 22-02-2024 22:05 | Q4 2023 Cijferpublicaties |
| 11-01-2024 00:45 | JPMorgan Healthcare Conference |
| 13-11-2023 22:45 | American Association for the Study of Liver Diseases Conference |
| 13-11-2023 21:00 | American Association for the Study of Liver Diseases Conference - Abstract No 5004 |
| 13-11-2023 19:00 | American Association for the Study of Liver Diseases Conference - Abstract No 48500 |
| 10-11-2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster No: 1326-C |
| 10-11-2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster No: 1457-C |
| 10-11-2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster No: 1511-C |
| 10-11-2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster No: 1480-C |
| 10-11-2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster No: 1379-C |
| 10-11-2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster No: 1257-C |
| 02-11-2023 21:30 | Q3 2023 Presentatie van de resultaten |
| 02-11-2023 21:05 | Q3 2023 Cijferpublicaties |
| 25-10-2023 16:00 | H.C. Wainwright NASH Investor Conference |
| 13-09-2023 | H.C. Wainwright Global Investment Conference |
| 12-09-2023 14:10 | Morgan Stanley Global Healthcare Conference |
Geschiedenis van de jaarlijkse publicaties
| Start boekjaar | december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Omzet Miljoen USD | Gepubliceerd Verwachting Spread | 8,09 9,15 -11.6% | 76,4 79,3 -3.73% | 1 095 906 20.96% | 1 616 1 674 -3.48% | 86,2 79,7 8.1% | 40,6 |
|
EBITDA Miljoen USD | Gepubliceerd Verwachting Spread | -173 -191 9.36% | -292 -274 -6.42% | 427 664 -35.78% | 840 1 035 -18.89% | -665 -662 -0.36% | -564 |
|
Bedrijfsresultaat (EBIT) Miljoen USD | Gepubliceerd Verwachting Spread | -178 -196 9.1% | -297 -280 -6.21% | 421 275 52.72% | 833 903 -7.69% | -684 -697 1.87% | -603 |
|
Resultaat voor belastingen (EBT) Miljoen USD | Gepubliceerd Verwachting Spread | -175 -193 9.35% | -299 -285 -4.72% | 550 463 18.77% | 754 777 -2.94% | -628 -660 4.8% | -555 |
|
Nettowinst (verlies) Miljoen USD | Gepubliceerd Verwachting Spread | -175 -193 9.26% | -299 -284 -5.1% | 529 365 44.82% | 516 597 -13.57% | -615 -626 1.76% | -571 |
|
WPA USD | Gepubliceerd Verwachting Spread | -5,76 -2,77 -107.76% | -2,51 -2,38 -5.29% | 3,96 2,74 44.45% | 3,83 4,37 -12.32% | -4,59 -4,66 1.5% | -4,20 |
| Datum van publicatie | 26/03/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Geschiedenis van de driemaandelijkse publicaties
| Start boekjaar | december | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Omzet Miljoen USD | Gepubliceerd Verwachting Spread | 813 623 30.48% | 1 232 811 51.96% | -40,6 211 -119.24% | 375 114 227.76% | 49,4 134 -63.19% | 63,0 50,1 25.67% | 3,80 22,4 -83.04% | 2,64 8,77 -69.92% | 16,8 11,2 50.21% | 11,7 | 9,06 | 9,35 | 12,5 | 40,1 |
|
EBITDA Miljoen USD | Gepubliceerd Verwachting Spread | 573 958 -40.15% | 1 015 369 175.39% | -224 12,3 -1920.26% | 197 237 -16.98% | -149 142 -204.39% | -138 -146 5.51% | -214 | -182 -186 2.11% | -135 -148 8.97% | -123 | -141 | -144 | -131 | |
|
Bedrijfsresultaat (EBIT) Miljoen USD | Gepubliceerd Verwachting Spread | 572 419 36.52% | 1 014 546 85.75% | -225 69,1 -426.15% | 195 -52,7 469.78% | -151 -50,0 -200.76% | -143 -124 -15.66% | -215 -177 -21.66% | -187 -185 -1.12% | -139 -166 16.1% | -156 | -154 | -160 | -151 | |
|
Resultaat voor belastingen (EBT) Miljoen USD | Gepubliceerd Verwachting Spread | 546 450 21.32% | 922 588 56.72% | -234 109 -314.43% | 218 -37,4 682.25% | -152 -48,9 -210.26% | -143 -144 0.55% | -198 -178 -11.18% | -167 -177 5.97% | -121 -152 20.65% | -141 | -138 | -140 | -136 | |
|
Nettowinst (verlies) Miljoen USD | Gepubliceerd Verwachting Spread | 525 353 48.94% | 519 475 9.26% | -76,5 76,4 -200.09% | 175 -8,88 2074.08% | -102 -46,0 -120.72% | -141 -115 -22.36% | -195 -168 -16.13% | -163 -167 2.37% | -116 -136 14.5% | -144 | -144 | -147 | -143 | |
|
WPA USD | Gepubliceerd Verwachting Spread | 3,92 2,63 49.22% | 3,85 3,54 8.76% | -0,58 0,26 -324.37% | 1,30 -0,07 2071.19% | -0,76 -0,34 -121.45% | -1,06 -0,86 -23.22% | -1,45 -1,25 -16.34% | -1,22 -1,25 2.03% | -0,86 -1,01 14.5% | -1,07 | -1,06 | -1,08 | -1,04 | |
| Datum van publicatie | 24/02/22 | 05/05/22 | 09/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | - | - | - | - | - |
| 02-05-2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Cijferpublicaties |
| 02-05-2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Cijferpublicaties (schatting) |
| 02-05-2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Cijferpublicaties (schatting) |
| 02-05-2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Cijferpublicaties (schatting) |
| 02-05-2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Cijferpublicaties (schatting) |
| 02-05-2024 | GALAPAGOS NV: Q1 2024 Cijferpublicaties |
| 02-05-2024 12:30 | MODERNA, INC.: Q1 2024 Cijferpublicaties |
| 02-05-2024 13:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Cijferpublicaties |
| 02-05-2024 13:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Cijferpublicaties |
| 02-05-2024 13:00 | IQVIA HOLDINGS INC.: Q1 2024 Cijferpublicaties |
